Hot Investor Mandate: Venture Arm of Spanish Investment Holding Company Looks to Invest in Therapeutics Companies Across All Disease Areas

A venture capital arm of a large Spanish investment holding company is actively seeking early-stage investment opportunities. A 100 million euros allocation of the fund is dedicated to life sciences investments, while the rest of the fund will focus on investing in manufacturing and digital technology. The typical size of investment can range from 1 to 5 million euros, but the firm has the capacity to invest more in following investments in portfolio companies. The firm can participate at any stage but with preference for investments in Series A and B rounds, and has invested in more than 30 companies. The firm is willing to both lead and co-invest in companies located in Spain and Portugal, and the firm will only participate as a co-investor in European and North American companies. The firm looks to tailor its services to help and collaborate with portfolio companies to reach key value-added milestones.

The firm is a flexible and opportunistic investor that is currently considering Therapeutics companies. The firm is opportunistic in terms of therapeutic areas. In terms of therapeutics, the firm will look at products of all stages from pre-clinical to phase I.

The firm will invest in privately held companies only. The firm seeks companies with a full-time management team with expertise, successful track records would be a plus but is not required. The firm takes a board seat in portfolio companies.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.